CONCERTO II/CONSULTA /MAXIMO II CRT-DS
FDA premarket approval P010031/S225 · decided 2011-01-13
Approval details
- PMA number
- P010031
- Supplement
- S225
- Supplement type
- 30-Day Notice
- Supplement reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Trade name
- CONCERTO II/CONSULTA /MAXIMO II CRT-DS
- Applicant
- Medtronic Cardiac Rhythm Disease Management
- Date received
- 2010-12-14
- Decision date
- 2011-01-13
- Days to decision
- 30 days
- Decision code
- OK30
- Advisory committee
- Cardiovascular
- Expedited review
- No
- Location
- Mounds View, MN
- Statement
- ACCEPTANCE OF AN UPGRADE OF THE D363 INTEGRATED CIRCUIT FOR CONTINUOUS TEST COVERAGE AND TEST METHODOLOGY.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.